Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s vitiligo toolkit.
Adam Friedman, MD, FAAD: Matching Patients to the Right Treatments for Atopic Dermatitis
Dr. Friedman discusses how to evaluate patients with atopic dermatitis to match them with their best treatment as well as the importance of keeping a detailed patient history in order to improve ease of access to the most effective medications.
John Harris, MD, PhD: Effective Treatment for Patients with Vitiligo
John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He explains how this treatment has shown exceptional efficacy with limited side effects.
Raj Chovatiya, MD, PhD: Itch in Atopic Dermatitis
Raj Chovatiya, MD, PhD, Director of the Center for Eczema and Itch at the Department of Dermatology at Northwestern University Feinberg School of Medicine, discusses how to distinguish when to use topical versus oral therapy in patients with atopic dermatitis.
Raj Chovatiya, MD, PhD: Itch Tales
Dr. Chovatiya recaps his session titled, “Itch Tales: Looking Beyond Atopic Dermatitis,” in which he and other eight experts discussed patients who presented with conditions that appeared to be eczema or atopic dermatitis, but ended up being something else entirely.